Folate Deficiency
Common cause of megaloblastic macrocytic anaemia due to reduced folate intake or increased demand. Unlike B12 deficiency, does NOT cause neurological damage. Critical in pregnancy for prevention of neural tube defects.
Key Facts
Macrocytic megaloblastic anaemia: identical haematological picture to B12 deficiency (oval macrocytes, hypersegmented neutrophils) NO neurological damage (unlike B12 deficiency) — key differentiating feature Causes: poor dietary intake (most common), increased demand (pregnancy, haemolytic anaemia, malignancy), malabsorption (coeliac, Crohn), drugs (methotrexate, trimethoprim, phenytoin, sodium valproate) Neural tube defects (NTDs): folic acid 400mcg daily pre-conception and for first 12 weeks of pregnancy reduces NTD risk by ~70% High-risk pregnancy: folic acid 5mg daily (previous NTD, diabetes, epilepsy on valproate/carbamazepine, BMI >30) Treatment: folic acid 5mg daily for 4 months; identify and treat underlying cause CRITICAL: always check B12 before starting folate — folate replacement in undiagnosed B12 deficiency may precipitate/worsen neurological damage (SACD) Red cell folate: more accurate than serum folate for tissue stores (less affected by recent intake)
Overview
Key Facts
Folate (vitamin B9) deficiency is a common cause of megaloblastic anaemia. Unlike B12 deficiency, it does not cause neurological damage. Folate supplementation in pregnancy is critical for preventing neural tube defects.
Epidemiology
- Common: estimated ~5% of UK population may have suboptimal folate
- Elderly, alcoholics, and lower socioeconomic groups at highest risk
- Pregnancy: increased demand → deficiency common without supplementation
Aetiology
- Dietary insufficiency (most common): poor intake of green vegetables, liver, fortified foods; alcoholism
- Increased demand: pregnancy, lactation, haemolytic anaemia (sickle cell, thalassaemia), malignancy, psoriasis, exfoliative dermatitis
- Malabsorption: coeliac disease, Crohn disease (proximal jejunum), tropical sprue
- Drugs: methotrexate (DHFR inhibitor), trimethoprim, phenytoin, carbamazepine, sodium valproate
Pathophysiology
- Folate is essential for one-carbon metabolism and DNA synthesis (thymidylate synthesis)
- Deficiency → impaired DNA synthesis → megaloblastic erythropoiesis
- Nuclear-cytoplasmic dissociation: delayed nuclear maturation with normal cytoplasmic maturation → large cells
- Body stores last only 3–4 months (cf. B12 stores last 3–5 years)
- Folate absorbed in proximal jejunum
Clinical Presentation
Haematological
- Anaemia symptoms: fatigue, dyspnoea, pallor
- Glossitis (smooth, red tongue)
- Mild jaundice (ineffective erythropoiesis)
No Neurological Features
- Key distinction from B12 deficiency
- If neurological signs present: suspect B12 deficiency (or combined)
Red Flags
- Neurological symptoms (suggests B12 deficiency — check both)
- Pancytopenia (severe deficiency; exclude other causes)
- Pregnancy with no folate supplementation (NTD risk)
- Suspected coeliac disease (weight loss, diarrhoea, iron deficiency)
Differential Diagnosis
| Diagnosis | Key Features | Investigation |
|---|---|---|
| B12 deficiency | Neurological damage (SACD), megaloblastic | B12, MMA |
| Hypothyroidism | Non-megaloblastic macrocytosis, fatigue | TFTs |
| Alcohol excess | Non-megaloblastic macrocytosis, raised GGT/MCV | GGT, history |
| Myelodysplasia | Cytopenia, dysplastic cells on film, elderly | Bone marrow biopsy |
| Liver disease | Macrocytosis, deranged LFTs | LFTs |
Diagnosis / Investigation
Bloods
- FBC: low Hb, raised MCV (>100 fL), ± pancytopenia
- Blood film: oval macrocytes, hypersegmented neutrophils (identical to B12 deficiency)
- Serum folate: low (<3 µg/L) — affected by recent dietary intake
- Red cell folate: more reliable for tissue stores (low <150 µg/L) — but less commonly available
- Serum B12: MUST check before starting folate (exclude B12 deficiency)
- Homocysteine: elevated (non-specific)
- MMA: NORMAL (distinguishes from B12 deficiency where MMA is elevated)
- LDH, bilirubin: elevated (ineffective erythropoiesis)
Special Tests
- Coeliac screen: anti-tTG (if unexplained folate deficiency)
- Reticulocyte count: low
Management
Pharmacological
- Folic acid 5mg daily for 4 months (standard treatment dose)
- Identify and treat underlying cause (diet, coeliac, drugs)
- CRITICAL: check and correct B12 deficiency BEFORE or alongside folate replacement
Pregnancy/Pre-conception
- All women: folic acid 400mcg daily from pre-conception through first 12 weeks
- High-risk (previous NTD, diabetes, BMI >30, epilepsy on valproate/carbamazepine, sickle cell/thalassaemia, coeliac): folic acid 5mg daily from pre-conception through first 12 weeks
Ongoing Supplementation
- If cause is ongoing (haemolytic anaemia, chronic malabsorption): long-term folic acid 5mg daily
- Methotrexate patients: folic acid 5mg once weekly (not on methotrexate day)
Dietary Advice
- Green leafy vegetables (spinach, broccoli, Brussels sprouts)
- Fortified cereals and bread
- Liver, legumes, oranges
Referral Criteria
- Haematology: pancytopenia, diagnostic uncertainty
- Gastroenterology: suspected coeliac or malabsorption
- Obstetrics: high-risk pregnancy
Prognosis
- Excellent with appropriate replacement
- Reticulocyte count rises within 5–7 days of starting treatment
- Hb normalises within 6–8 weeks
- Stores replenished within 4 months
- Folate supplementation: reduces NTD risk by ~70% (400mcg); high dose (5mg) for high-risk
- If underlying cause treated: folate deficiency unlikely to recur
- Long-term folate needed if ongoing cause (haemolysis, malabsorption)
Other Relevant Information
Drugs Causing Folate Deficiency
| Drug | Mechanism |
|---|---|
| Methotrexate | Inhibits dihydrofolate reductase (DHFR) |
| Trimethoprim | Inhibits bacterial DHFR (can affect human at high doses) |
| Phenytoin | Impairs folate absorption |
| Carbamazepine | Impairs folate absorption |
| Sodium valproate | Unclear mechanism; NTD risk in pregnancy |